703 filings
ARS
2023 FY
ADAP
Adaptimmune Therapeutics Plc
22 Apr 24
Annual report to shareholders
5:15pm
8-K
ADAP
Adaptimmune Therapeutics Plc
12 Apr 24
Company remains focused on launching afami-cel later this year with a PDUFA date of August 4th and developing its broader sarcoma franchise
8:05am
DEF 14A
ADAP
Adaptimmune Therapeutics Plc
Definitive proxy
11 Apr 24
8:00am
SC 13D/A
ADAP
Adaptimmune Therapeutics Plc
2 Apr 24
Adaptimmune Therapeutics / New Enterprise Associates 14 ownership change
8:38pm
PRE 14A
ADAP
Adaptimmune Therapeutics Plc
Preliminary proxy
1 Apr 24
8:01am
3
ADAP
Adaptimmune Therapeutics Plc
26 Mar 24
Initial statement of insider ownership
12:00pm
SC 13G/A
ADAP
Adaptimmune Therapeutics Plc
26 Mar 24
Adaptimmune Therapeutics / EcoR1 Capital ownership change
11:59am
4
Cintia Piccina
18 Mar 24
Adaptimmune Therapeutics / Cintia Piccina ownership change
5:00pm
10-K
2023 FY
ADAP
Adaptimmune Therapeutics Plc
Annual report
6 Mar 24
7:12am
8-K
ADAP
Adaptimmune Therapeutics Plc
6 Mar 24
Adaptimmune Reports Q4 /Full Year 2023 Financial Results and Business Updates
7:05am
8-K
ADAP
Adaptimmune Therapeutics Plc
27 Feb 24
Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company’s Sarcoma Franchise
8:13am
8-K
ADAP
Adaptimmune Therapeutics Plc
16 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
SC 13G/A
ADAP
Adaptimmune Therapeutics Plc
14 Feb 24
Adaptimmune Therapeutics / Long Focus Capital Management ownership change
5:04pm
SC 13G/A
Baker Bros. Advisors LP
14 Feb 24
Adaptimmune Therapeutics / BAKER BROS. ADVISORS ownership change
4:21pm
8-K
ADAP
Adaptimmune Therapeutics Plc
31 Jan 24
Other Events
5:07pm
SC 13G
ADAP
Adaptimmune Therapeutics Plc
30 Jan 24
Adaptimmune Therapeutics / EcoR1 Capital ownership change
5:26pm
SC 13G/A
Baillie Gifford & Co
29 Jan 24
Adaptimmune Therapeutics / BAILLIE GIFFORD & CO ownership change
11:52am
4
ADAP
Adaptimmune Therapeutics Plc
17 Jan 24
Adaptimmune Therapeutics / Adrian Rawcliffe ownership change
5:31pm
4
Elliot Norry
17 Jan 24
Adaptimmune Therapeutics / Elliot Norry ownership change
5:31pm
4
John Lunger
17 Jan 24
Adaptimmune Therapeutics / John Lunger ownership change
5:30pm